.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
QuintilesIMS
Healthtrust
Harvard Business School
Merck
Julphar
McKinsey
Mallinckrodt
US Army
Chubb

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077224

« Back to Dashboard

NDA 077224 describes RIBAVIRIN, which is a drug marketed by Sandoz, Teva, Zydus Pharms Usa, Navinta Llc, Aurobindo Pharma, Kadmon Pharms Llc, and Sandoz Inc, and is included in ten NDAs. It is available from eleven suppliers. Additional details are available on the RIBAVIRIN profile page.

The generic ingredient in RIBAVIRIN is ribavirin. There are fifteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the ribavirin profile page.

Summary for 077224

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details

Pharmacology for NDA: 077224

Ingredient-typeNucleoside Analog

Medical Subject Heading (MeSH) Categories for 077224

Suppliers and Packaging for NDA: 077224

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RIBAVIRIN ribavirin CAPSULE;ORAL 077224 ANDA State of Florida DOH Central Pharmacy 53808-0782 53808-0782-1 30 TABLET, FILM COATED in 1 BLISTER PACK (53808-0782-1)
RIBAVIRIN ribavirin CAPSULE;ORAL 077224 ANDA Cadila Healthcare Limited 65841-260 65841-260-03 168 CAPSULE in 1 BOTTLE (65841-260-03)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength200MG
Approval Date:Oct 28, 2005TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Federal Trade Commission
Johnson and Johnson
Healthtrust
Merck
Queensland Health
Medtronic
Citi
Cipla
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot